CAMBRIDGE, Mass.--Based on the success of their current partnership, Pfizer will expand its collaboration with Millennium Pharmaceuticals here for the discovery of unique antifungal drug targets and leads. As part of the expansion Pfizer will add more research personnel. The relationship began in March 1995 as a collaboration with ChemGenics Pharmaceuticals, which merged with Millennium a year ago.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.